Comparison - BNR - NASDAQ

Weiss Ratings	BNR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Rating	D
Reward Index	Very Weak
Risk Index	Weak
Risk Grade	D-
Reward Grade	E

Rating Factors	BNR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Fair
Efficiency Index	Very Weak
Solvency Index	Excellent
Total Return Index	Very Weak
Volatility Index	Weak

Beta / Standard Deviation	BNR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Beta	0.54

Price History	BNR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	12.94%
30-Day Total Return	-11.38%
60-Day Total Return	-6.34%
90-Day Total Return	71.43%
Year to Date Total Return	-22.06%
1-Year Total Return	-16.52%
2-Year Total Return	-80.14%
3-Year Total Return	-93.48%
5-Year Total Return	--
52-Week High % Change	-38.82%
52-Week Low % Change	109.92%

Price	BNR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$8.99
52-Week Low Price	$2.62
52-Week Low Price (Date)	Sep 24, 2024
52-Week High Price (Date)	May 15, 2024

Valuation	BNR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Market Cap	56.42M
Enterprise Value	-184.32K
Price/Earnings (TTM)	--
Earnings Per Share (TTM)	-43.29
Earnings Per Share Growth	-55.85%
Price/Earnings To Growth	--
Price/Sales (TTM)	0.11
Price/Book (Q)	0.06
Enterprise Value/Revenue (TTM)	0.00
Price	$5.76
Enterprise Value/EBITDA (TTM)	0.01
Enterprise Value/EBIT	0.00
Market Cap Category	Micro Cap

Dividends and Shares	BNR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	1.03M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	BNR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Phone Number	86 20 3403 7871
Address	--
Website	www.brbiotech.com
Country	China
Year Founded	2014

Profitability	BNR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	--
Profit Margin	--

Management Effectiveness	BNR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Return on Assets	--
Return on Equity	--

Income Statement	BNR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	--
Total Revenue (TTM)	--
Revenue Per Share	$50.61
Gross Profit (TTM)	--
EBITDA (TTM)	--
EBIT (TTM)	--
Net Income (TTM)	--
Net Income Avl. to Common (TTM)	--
Total Revenue Growth (Q YOY)	2.03%
Earnings Growth (Q YOY)	79.33%
EPS Diluted (TTM)	--
EPS Diluted Growth (Q YOY)	79.51%

Balance Sheet	BNR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	70.99M
Cash Per Share (Q)	$68.78
Total Current Assets (Q)	111.89M
Total Preferred Equity (Q)	--
Total Equity (Q)	92.40M
Current Ratio (Q)	3.036
Book Value Per Share (Q)	$89.52
Total Assets (Q)	140.40M
Total Current Liabilities (Q)	36.85M
Total Debt (Q)	14.38M
Total Liabilities (Q)	47.99M
Total Common Equity (Q)	92.40M

Cash Flow	BNR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	--
Cash from Financing (TTM)	--
Net Change in Cash (TTM)	--
Levered Free Cash Flow (TTM)	--
Cash from Operations (TTM)	--